Skip to main content
. 2025 Mar 7;77(2):75. doi: 10.1007/s10616-025-00736-4

Table 2.

Pathway analysis of the 89 genes whose expression was altered by pseudo-CAD/PVD medium treatment

Pathway EGM2
Vascular networking 0 h
Pseudo-CAD/PVD
Vascular networking 0 h
D-myo-inositol(1,4,5,6)-tetrakisphosphate biosynthesis
 Inositol-polyphosphate kinase/phosphatase  − 3.23535  − 3.09952
Superpathway of D-myo-inositol(1,4,5)-trisphosphate metabolism
 Phosphatidyl inositol-4,5-bisphosphate5-phosphatase, A  − 3.62858  − 4.70854
Superpathway of inositol phosphate compounds
 Phosphatidylinositol-4,5,-Bisophosphate Phosphodiesterase Delta-4  − 6.13524  − 4.28159
 Inositol-Polyphosphate kinase/Phosphatase  − 3.23535  − 3.09952
 1-Phosphatidylinositol-4,5-Bisphosphate Phosphodiesterase Beta-1  − 0.45287  − 0.88368
 Phosphatidylinositol-5-Phosphate4-Kinase  − 1.47582  − 1.22685
 Phosphatidylinositol 4 Kinase Alpha  − 0.08661  − 0.64323
 Phosphatidylinositol 3-Kinase, Classib, P110gamma/P101/  − 4.73091  − 6.06731
Phosphoinositide-3-Kinase Regulatory Subunit P101
 Phosphatidylinositol-4,5-Bisophosphate 5-Phosphatase, A  − 3.62858  − .4.70854